^○Taro Okunomiya^1,2,3, Hiroyuki Hioki⁴, Chika Nishimura¹, Satoshi Yawata¹, Itaru Imayoshi⁵, Ryoichiro Kageyama⁶, Ryosuke Takahashi², Dai Watanabe¹ (1.Department of Biological Sciences, Graduate School of Medicine, Kyoto University, Japan, 2.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan, 3.Institute for Advancement of Clinical and Translational Science (iACT), Kyoto University Hospital, Japan, 4.Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine, 5.Laboratory of Brain Development and Regeneration, Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University, 6.Laboratory of Growth Regulation System, Institute for Frontier Life and Medical Sciences, Kyoto University)

^○Deepika D. Singh (SHUATS, Prayagraj, India)

^○Hidefumi Suzuki^1,2,3, Naohiro Egawa^1,2,3, Takayuki Kondo^2,3,4, Keiko Imamura^2,3,4, Mika Suga^2,3, Kayoko Tsukita^2,3, Takako Enami^3,4, Ran Shibukawa^2,3, Yasue Okanishi², Haruhisa Inoue^2,3,4, Ryosuke Takahashi¹ (1.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 2.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Japan, 3.Center for iPS Cell Research and Application (CiRA), Japan, 4.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP))